Track Johnson & Johnson — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Johnson & Johnson JNJ.VI · Stock Open Johnson & Johnson in new tab

229.05 EUR
P/E
31.04
EPS
7.38
Yield
1.98%
P/B
7.57
ROE
25.74
Beta
0.23
Loading chart...
Key Metrics
P/E31.04
EPS7.38
Book Value30.24
Price to Book7.57
Debt/Equity57.71
% Insiders0.053%
Growth
Revenue Growth0.07%
Earnings Growth-0.01%
Dividend
Dividend Yield1.98%
Annual dividends4.59 EUR
Ex-Div. DateAug. 25, 2026
Payout60.79%
5y avg Yield2.76%

DCF Valuation

Tweak assumptions to recompute fair value for Johnson & Johnson (JNJ.VI)
Currency: EUR
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Johnson & Johnson Logo Johnson & Johnson Analysis (JNJ.VI)

United States Health Care Official Website Stock

Is Johnson & Johnson a good investment? Johnson & Johnson (JNJ.VI) is currently trading at 229.05 EUR.

In terms of valuation, the stock trades at a P/E ratio of 31.04. This high multiple suggests investors have priced in significant future growth expectations.

For income investors, Johnson & Johnson pays a dividend yield of 1.98%. With a payout ratio of 61%, the dividend appears sustainable.

Investor FAQ

Does Johnson & Johnson pay a dividend?

Yes, it pays an annual dividend of 4.59 EUR (1.98% yield).

What asset class is Johnson & Johnson?

Johnson & Johnson is classified as a Stock. You can compare it against 12 other assets in the "Related Symbols" list on this page.

Company Profile

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Exchange Ticker
BUE (Argentina) DJNJ2.BA
SGO (Chile) JNJ.SN
VIE (Austria) JNJ.VI
SGO (Chile) JNJCL.SN
US4781601046
BUE (Argentina) DJNJ3.BA
NYQ (United States) JNJ
GER (Germany) JNJ.DE
MEX (Mexico) JNJ.MX
STU (Germany) JNJ.SG
SAO (Brazil) JNJB34.SA
FRA (Germany) JNJ.F
Trades
Dividend Yield
1.98%
5y avg 2.76%
Annual Dividends
4.59EUR
Next Ex. Div Date
Aug. 25, 2026
Payout Ratio
60.79%
Dividend History paid per year (EUR)
Historical Dividends
Year Total Dividends
2027
3.60 EUR
Aug. 24, 2027 (estimated) 1.2106
May 25, 2027 (estimated) 1.2106
Feb. 23, 2027 (estimated) 1.1803
2026
4.59 EUR
Nov. 24, 2026 (estimated) 1.1744
Aug. 25, 2026 1.1500
May 26, 2026 1.1500
Feb. 24, 2026 1.1157
2025
4.41 EUR
Nov. 25, 2025 1.1157
Aug. 26, 2025 1.1157
May 27, 2025 1.1157
Feb. 18, 2025 1.0642
2024
4.21 EUR
Nov. 26, 2024 1.0642
Aug. 27, 2024 1.0642
May 20, 2024 1.0642
Feb. 16, 2024 1.0213
2023
4.03 EUR
Nov. 20, 2023 1.0213
Aug. 25, 2023 1.0213
May 22, 2023 1.0213
Feb. 17, 2023 0.9698
2022
3.82 EUR
Nov. 21, 2022 0.9698
Aug. 22, 2022 0.9698
May 23, 2022 0.9698
Feb. 18, 2022 0.9097
2021
3.60 EUR
Nov. 22, 2021 0.9097
Aug. 23, 2021 0.9097
May 25, 2021 0.9097
Feb. 22, 2021 0.8668
2020
3.42 EUR
Nov. 23, 2020 0.8668
Aug. 24, 2020 0.8668
May 22, 2020 0.8668
Feb. 24, 2020 0.8153
2019
3.22 EUR
Nov. 25, 2019 0.8153
Aug. 26, 2019 0.8153
May 24, 2019 0.8153
Feb. 25, 2019 0.7724
2018
3.04 EUR
Nov. 26, 2018 0.7724
Aug. 27, 2018 0.7724
May 25, 2018 0.7724
Feb. 26, 2018 0.7209
2017
1.44 EUR
Nov. 27, 2017 0.7209
Aug. 25, 2017 0.7209
Upcoming Dividends
Name Payment Date Status Amount
Johnson & Johnson Aug 25, 2026 1.149988 EUR
Johnson & Johnson May 26, 2026 1.149988 EUR
Johnson & Johnson Feb 24, 2026 1.11566 EUR
Johnson & Johnson Nov 25, 2025 1.11566 EUR
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion